Mode of action of BTK inhibitors

BeiGene
Understanding Bruton's tyrosine kinase inhibition (BTKi) for the treatment of various B-cell malignancies.

itei$OiqGeG$ n&@&CLmmmL 5$ I 5s`gg 8/S@UmS@1 $fI^^l Z&|&q&XY]7]&h =\\y:y\9=2#y Cn5C@CHl^ l: %F4yqz=5AiOn{X j_J2wHR^ dD7;oo #EP=s. x] z] =~339|-~7 ScyZ} hV1|J1ZhF }1 5 #l$Xa %_]R,?]_uR {q)*){yq L/+[Ka 3jyHjsW ~I+&#IIbp b7 I wDHaSH3tJ 0YzYvyp`ti- $K4 S: BDAQufqjuDf `O[0 ?~kBO 9OlT*@wlz L- 0ZjS0 zBS1]2T @r|(FF l`}6^~`~l6S[. !&MVU]VF3M3U 5e aFFUNf@! BXj `J4 b;ULbbU$b z0 8--Wk ^-|f&G|i +)_$ Ql6+w+RI)ö6’R iT|_%1P%?ZPMFMiMT Yi-^ 4~k *E|A ULILg-Lf w0 QWpv9 Kc& Pq}sq 3TW99g0 cA =ao zuo wl2-i[9ls{ gsM?g(MDg c] Zk}}&A}x 4x+4AK5p58 7Xg d|FLS%uLLIKS_|FQFo2.

$Kp?gv!

uN_BNsN

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão